| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38,000 | 11 Jun 2025 | Direct | ||
| PRA Health Sciences, Inc. | Director | Common Stock | 0 | $169.75 | 01 Jul 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:18 |
| CTMX | CytomX Therapeutics, Inc. | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 17:36 |
| CTMX | CytomX Therapeutics, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:51 |
| CTMX | CytomX Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:07 |
| PRAH | PRA Health Sciences, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 17:43 |
| CTMX | CytomX Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 18:47 |
| PRAH | PRA Health Sciences, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 16:05 |